Acclaro Medical Announces FDA Clearance of UltraClear® Cold Ablative Fractional 2910 nm Fiber Laser for Treatment of Benign Pigmented Lesions and Vascular Dyschromia

Acclaro Medical, a medical technology company that specializes in developing and delivering trailblazing solutions for medical aesthetics and surgical practitioners worldwide, today announced clearance by the U.S. Food and Drug Administration (FDA) for a new indication of the Company’s UltraClear® cold ablative fractional 2910 nm fiber laser.

UltraClear®, The World’s First Cold Fiber Laser, Wins Major Beauty Award for “Best Laser Treatment for All Skin Tones” – Second Year in a Row

Acclaro Medical announced that UltraClear® was awarded the “Best Laser Treatment for All Skin Tones – 2024” from NewBeauty Magazine. The win in this highly regarded and very popular publication is a repeat favorite for the second year in a row, having secured the coveted award for UltraClear laser in 2023.

UltraClear Laser Pioneers Comfort with Revolutionary Laser Technology

As technology continues to evolve, Acclaro Medical adapts to technological advancements, pushes boundaries, and fosters positive change in the aesthetic industry.

MellingMedical to Deliver Acclaro’s UltraClear Cold Fiber Laser Technology to Federal Health Facilities

MellingMedical today announced a new distribution relationship with Acclaro Medical, an emerging leader in energy-based non-invasive, aesthetic medical devices.

Acclaro Medical Unveils Rebranding of Flagship Product UltraClear Cold Fiber Laser, Paving the Way for Next-Level Innovation and Customer Engagement

Acclaro Corporation Highlights Clinical Study Results of UltraClear™ Cold Ablative Fiber Laser for Skin Resurfacing at American Society of Laser Medicine and Surgery 2023 Annual Conference

World’s First Cold Ablative Fiber Laser for Anti-Aging UltraClear™ Technology Wins Major Beauty Award – 2023